Abstract
Adrenaline, noradrenaline, isoprenaline, and to a lesser extent dopamine inhibit the release of leukotriene (LT) B2 from calcium ionophore-stimulated human polymorphonuclear leukocytes, while the release of prostaglandin (PG) E2 is proportionally elevated. The inactivity of salbutamol, a noncatechol adrenergic beta 2-receptor agonist, and the inability of propranolol to antagonize the effects of adrenaline, suggest the mediation through beta-receptor independent mechanisms. Neither are alpha-1-receptors involved, as prazosin, a specific antagonist, fails to inhibit the reaction. As the principles for biochemical regulation of LT- and PG-production are met by catecholamines in several tissues, the mechanism is considered to be of general physiological importance. Catecholamines may function as coenzymes/antioxidants which, by altering the redox state of the enzyme iron or heme, decrease the LT/PG ratio thus protecting the organism against tissue anaphylaxis and other LT-related pathophysiology.
References
Jan 1, 1979·Gut·T A Miller, E D Jacobson
Jan 1, 1988·Stroke; a Journal of Cerebral Circulation·T TsukaharaH Handa
Jul 1, 1988·Agents and Actions·E MoilanenH Vapaatalo
Nov 3, 1987·Biochemistry·C KemalA L Shorter
Nov 1, 1985·Prostaglandins, Leukotrienes, and Medicine·K LaustiolaH Vapaatalo
Aug 1, 1970·Agents and Actions·H Vapaatalo, H Karppanen
Jul 31, 1969·The New England Journal of Medicine·A A Mathé, P H Knapp
Sep 1, 1984·The Journal of Allergy and Clinical Immunology·A W Ford-Hutchinson
Nov 9, 1984·Journal of Chromatography·F J Zijlstra, J E Vincent
Jul 31, 1980·The New England Journal of Medicine·P BarnesC Dollery
Mar 1, 1980·Inflammation·A L SagoneC DeMocko
Jan 17, 1984·Biochimica Et Biophysica Acta·Y KoshiharaT Tatsuno
May 1, 1984·Biochemical Pharmacology·R LandolfiM Steiner
Jan 1, 1984·Prostaglandins, Leukotrienes, and Medicine·H SalariP Borgeat
May 1, 1984·Prostaglandins, Leukotrienes, and Medicine·E SeppäläT Metsä-Ketelä
Nov 30, 1981·Biochemical and Biophysical Research Communications·S S Yen, H G Morris
Feb 2, 1981·Life Sciences·D S GoldsteinH R Keiser
Citations
Oct 15, 1995·Thrombosis Research·T KerttulaJ Alanko
Sep 1, 1991·Prostaglandins·J AlankoI Mucha
Mar 1, 1993·Prostaglandins·J Alanko
Dec 1, 1992·Free Radical Biology & Medicine·J AlankoH Vapaatalo
Jan 1, 1993·Free Radical Biology & Medicine·J AlankoT Metsä-Ketelä
Dec 31, 1997·Biochemical Pharmacology·J AlankoJ Parantainen
Apr 14, 1999·Life Sciences·M CosentinoG Frigo
Jan 16, 1999·Free Radical Biology & Medicine·J AlankoT Metsä-Ketelä
Oct 1, 1993·American Journal of Obstetrics and Gynecology·S A Laifer, P N Rauk
Sep 1, 1994·Pediatric Pulmonology·T ShimizuB Strandvik
Jul 28, 2001·European Journal of Anaesthesiology·M G RorariusP Laippala
Jan 1, 1992·Scandinavian Journal of Gastroenterology·P A Aho, I B Lindén
Jan 16, 1999·Journal of Cardiovascular Pharmacology·T KerttulaS Kaukinen
Jan 1, 1993·Life Sciences·J P MartinolleR Garcia-Villar
May 1, 1995·Prostaglandins, Leukotrienes, and Essential Fatty Acids·J AlankoH Vapaatalo
Jul 1, 1995·Prostaglandins, Leukotrienes, and Essential Fatty Acids·T KerttulaJ Alanko
Aug 31, 2021·Frontiers in Immunology·Hazel OzunaDonald R Demuth